Athalia rosae chromosome 8, iyAthRosa1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Tenthredinoidea; Tenthredinidae; Allantinae; Athalia.
REFSEQ INFORMATION: The reference sequence is identical to\nOU795007.1.\nAssembly name: iyAthRosa1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/10/13. The original whole-genome shotgun project has the\naccession CAKJPL000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Athalia rosae Annotation Release 103\nAnnotation Version :: 103\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
negative elongation factor B, transcript variant X2
negative elongation factor B, transcript variant X1
negative elongation factor B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
uncharacterized LOC105684917, transcript variant X1
uncharacterized LOC105684917, transcript variant X2
uncharacterized LOC105684917, transcript variant X3
uncharacterized protein LOC105684917 isoform X1
uncharacterized protein LOC105684917 isoform X2
uncharacterized protein LOC105684917 isoform X3
mismatch repair endonuclease PMS2, transcript variant X1
mismatch repair endonuclease PMS2, transcript variant X2
mismatch repair endonuclease PMS2 isoform X1
mismatch repair endonuclease PMS2 isoform X2
uncharacterized LOC105684911, transcript variant X3
uncharacterized LOC105684911, transcript variant X4
uncharacterized LOC105684911, transcript variant X1
uncharacterized LOC105684911, transcript variant X2
uncharacterized protein LOC105684911 isoform X2
uncharacterized protein LOC105684911 isoform X1
dual oxidase maturation factor 1-like, transcript variant X6
dual oxidase maturation factor 1-like, transcript variant X5
dual oxidase maturation factor 1-like, transcript variant X3
dual oxidase maturation factor 1-like, transcript variant X4
dual oxidase maturation factor 1-like, transcript variant X1
dual oxidase maturation factor 1-like, transcript variant X2
dual oxidase maturation factor 1-like isoform X1
dual oxidase maturation factor 1-like isoform X2
dual oxidase maturation factor 1-like isoform X3
dual oxidase maturation factor 1-like isoform X4
probable splicing factor, arginine/serine-rich 7
WD repeat-containing protein 35, transcript variant X1
WD repeat-containing protein 35, transcript variant X2
WD repeat-containing protein 35 isoform X1
WD repeat-containing protein 35 isoform X2
protein O-mannosyl-transferase TMTC4, transcript variant X2
protein O-mannosyl-transferase TMTC4, transcript variant X1
protein O-mannosyl-transferase TMTC4, transcript variant X5
protein O-mannosyl-transferase TMTC4, transcript variant X6
protein O-mannosyl-transferase TMTC4, transcript variant X4
protein O-mannosyl-transferase TMTC4, transcript variant X3
protein O-mannosyl-transferase TMTC4 isoform X1
protein O-mannosyl-transferase TMTC4 isoform X3
protein O-mannosyl-transferase TMTC4 isoform X4
protein O-mannosyl-transferase TMTC4 isoform X5
protein O-mannosyl-transferase TMTC4 isoform X6
protein O-mannosyl-transferase TMTC4 isoform X2
snRNA-activating protein complex subunit 3, transcript variant X2
snRNA-activating protein complex subunit 3, transcript variant X1
snRNA-activating protein complex subunit 3 isoform X2
snRNA-activating protein complex subunit 3 isoform X1
ribonucleoside-diphosphate reductase subunit M2 B, transcript variant X1
ribonucleoside-diphosphate reductase subunit M2 B, transcript variant X4
ribonucleoside-diphosphate reductase subunit M2 B, transcript variant X5
ribonucleoside-diphosphate reductase subunit M2 B, transcript variant X6
ribonucleoside-diphosphate reductase subunit M2 B, transcript variant X3
ribonucleoside-diphosphate reductase subunit M2 B, transcript variant X2
ribonucleoside-diphosphate reductase subunit M2 B isoform X1
ribonucleoside-diphosphate reductase subunit M2 B isoform X2
ribonucleoside-diphosphate reductase subunit M2 isoform X3
ribonucleoside-diphosphate reductase subunit M2 B isoform X4
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X9
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X10
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X11
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X12
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X7
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X13
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X2
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X4
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X8
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X6
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X3
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X1
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X6
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X9
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X1
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X3
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X2
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X8
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X7
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X5
eukaryotic translation initiation factor 4E-binding protein Mextli, transcript variant X5
eukaryotic translation initiation factor 4E-binding protein Mextli isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
uncharacterized LOC105684901, transcript variant X2
uncharacterized LOC105684901, transcript variant X1
uncharacterized LOC105684901, transcript variant X3
uncharacterized protein LOC105684901 isoform X2
uncharacterized protein LOC105684901 isoform X1
gamma-tubulin complex component 5, transcript variant X1
gamma-tubulin complex component 5, transcript variant X3
gamma-tubulin complex component 5, transcript variant X2
gamma-tubulin complex component 5, transcript variant X4
gamma-tubulin complex component 5, transcript variant X5
gamma-tubulin complex component 5, transcript variant X6
gamma-tubulin complex component 5 isoform X4
gamma-tubulin complex component 5 isoform X2
gamma-tubulin complex component 5 isoform X3
gamma-tubulin complex component 5 isoform X1
gamma-tubulin complex component 5 isoform X5
gamma-tubulin complex component 5 isoform X6
tudor domain-containing protein 7-like, transcript variant X1
tudor domain-containing protein 7-like, transcript variant X3
tudor domain-containing protein 7-like, transcript variant X2
tudor domain-containing protein 7-like isoform X1
tudor domain-containing protein 7-like isoform X2
uncharacterized LOC110116939, transcript variant X2
uncharacterized LOC110116939, transcript variant X1
WD repeat-containing protein 19-like, transcript variant X5
WD repeat-containing protein 19-like, transcript variant X9
WD repeat-containing protein 19-like, transcript variant X10
WD repeat-containing protein 19-like, transcript variant X7
WD repeat-containing protein 19-like, transcript variant X8
WD repeat-containing protein 19-like, transcript variant X4
WD repeat-containing protein 19-like, transcript variant X6
WD repeat-containing protein 19-like isoform X2
endonuclease/exonuclease/phosphatase family domain-containing protein 1-like
centromere protein I-like, transcript variant X1
centromere protein I-like, transcript variant X2
centromere protein I-like, transcript variant X3
DNA (cytosine-5)-methyltransferase 1-like, transcript variant X1
DNA (cytosine-5)-methyltransferase 1-like isoform X1
DNA (cytosine-5)-methyltransferase 1-like, transcript variant X2
DNA (cytosine-5)-methyltransferase 1-like isoform X2
importin subunit beta-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
importin subunit beta-1, transcript variant X2
metallo-beta-lactamase domain-containing protein 1, transcript variant X1
metallo-beta-lactamase domain-containing protein 1, transcript variant X2
metallo-beta-lactamase domain-containing protein 1 isoform X2
metallo-beta-lactamase domain-containing protein 1 isoform X1
FAD-dependent oxidoreductase domain-containing protein 1
28S ribosomal protein S14, mitochondrial
dTTP/UTP pyrophosphatase, transcript variant X4
dTTP/UTP pyrophosphatase, transcript variant X1
dTTP/UTP pyrophosphatase, transcript variant X2
dTTP/UTP pyrophosphatase, transcript variant X3
probable bifunctional dTTP/UTP pyrophosphatase/methyltransferase protein isoform X4
L-lactate dehydrogenase (cytochrome), transcript variant X1
L-lactate dehydrogenase (cytochrome), transcript variant X3
L-lactate dehydrogenase (cytochrome), transcript variant X2
L-lactate dehydrogenase (cytochrome) isoform X1
L-lactate dehydrogenase (cytochrome) isoform X2
L-lactate dehydrogenase (cytochrome) isoform X3
uncharacterized LOC105684925, transcript variant X1
uncharacterized LOC105684925, transcript variant X2
uncharacterized LOC105684925, transcript variant X5
uncharacterized LOC105684925, transcript variant X3
uncharacterized LOC105684925, transcript variant X4
uncharacterized LOC125502041, transcript variant X6
uncharacterized LOC125502041, transcript variant X5
uncharacterized LOC125502041, transcript variant X4
uncharacterized LOC125502041, transcript variant X3
uncharacterized LOC125502041, transcript variant X2
uncharacterized LOC125502041, transcript variant X1
uncharacterized protein LOC125502041 isoform X1
uncharacterized protein LOC125502041 isoform X2
WD repeat-containing protein 19-like, transcript variant X1
WD repeat-containing protein 19-like, transcript variant X2
WD repeat-containing protein 19-like, transcript variant X3
WD repeat-containing protein 19-like isoform X1
uncharacterized LOC125502042, transcript variant X2
uncharacterized LOC125502042, transcript variant X1
TATA box-binding protein-like 1, transcript variant X1
TATA box-binding protein-like 1, transcript variant X2
zinc transporter ZIP6, transcript variant X2
zinc transporter ZIP6, transcript variant X1
RCC1 and BTB domain-containing protein 1-like, transcript variant X3
RCC1 and BTB domain-containing protein 1-like, transcript variant X2
RCC1 and BTB domain-containing protein 1-like, transcript variant X1
RCC1 and BTB domain-containing protein 1-like isoform X1
RCC1 and BTB domain-containing protein 1-like isoform X3
RCC1 and BTB domain-containing protein 1-like isoform X2
uncharacterized LOC105683855, transcript variant X4
uncharacterized LOC105683855, transcript variant X1
uncharacterized protein LOC105683855 isoform X4
uncharacterized protein LOC105683855 isoform X1
uncharacterized LOC105683855, transcript variant X3
uncharacterized protein LOC105683855 isoform X3
uncharacterized LOC105683855, transcript variant X2
uncharacterized protein LOC105683855 isoform X2
probable multidrug resistance-associated protein lethal(2)03659
ATP-binding cassette sub-family C member 4-like, transcript variant X1
ATP-binding cassette sub-family C member 4-like, transcript variant X5
ATP-binding cassette sub-family C member 4-like, transcript variant X3
ATP-binding cassette sub-family C member 4-like, transcript variant X2
ATP-binding cassette sub-family C member 4-like, transcript variant X4
ATP-binding cassette sub-family C member 4-like isoform X1
ATP-binding cassette sub-family C member 4-like isoform X2
very long-chain specific acyl-CoA dehydrogenase, mitochondrial
probable glutamate--tRNA ligase, mitochondrial, transcript variant X6
probable glutamate--tRNA ligase, mitochondrial, transcript variant X7
probable glutamate--tRNA ligase, mitochondrial, transcript variant X5
probable glutamate--tRNA ligase, mitochondrial, transcript variant X4
probable glutamate--tRNA ligase, mitochondrial, transcript variant X3
probable glutamate--tRNA ligase, mitochondrial, transcript variant X2
probable glutamate--tRNA ligase, mitochondrial, transcript variant X1
uncharacterized protein LOC125502098 isoform X1
probable glutamate--tRNA ligase, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
histone demethylase UTY, transcript variant X1
histone demethylase UTY, transcript variant X2
histone demethylase UTY, transcript variant X3
histone demethylase UTY, transcript variant X4
lysine-specific demethylase 6A isoform X4
FUN14 domain-containing protein 1A, transcript variant X1
FUN14 domain-containing protein 1A, transcript variant X3
FUN14 domain-containing protein 1A, transcript variant X4
FUN14 domain-containing protein 1A, transcript variant X2
FUN14 domain-containing protein 1A isoform X1
FUN14 domain-containing protein 1A isoform X2
FUN14 domain-containing protein 1A isoform X3
integrator complex subunit 9, transcript variant X4
integrator complex subunit 9, transcript variant X5
integrator complex subunit 9, transcript variant X3
integrator complex subunit 9, transcript variant X2
integrator complex subunit 9, transcript variant X1
integrator complex subunit 9, transcript variant X6
uncharacterized LOC105683911, transcript variant X12
uncharacterized LOC105683911, transcript variant X9
uncharacterized LOC105683911, transcript variant X7
uncharacterized LOC105683911, transcript variant X6
uncharacterized LOC105683911, transcript variant X18
uncharacterized LOC105683911, transcript variant X3
uncharacterized LOC105683911, transcript variant X22
uncharacterized LOC105683911, transcript variant X4
uncharacterized LOC105683911, transcript variant X10
uncharacterized LOC105683911, transcript variant X13
uncharacterized LOC105683911, transcript variant X15
uncharacterized LOC105683911, transcript variant X11
uncharacterized LOC105683911, transcript variant X14
uncharacterized LOC105683911, transcript variant X5
uncharacterized LOC105683911, transcript variant X1
uncharacterized LOC105683911, transcript variant X21
uncharacterized LOC105683911, transcript variant X8
uncharacterized LOC105683911, transcript variant X20
uncharacterized LOC105683911, transcript variant X16
uncharacterized LOC105683911, transcript variant X17
uncharacterized LOC105683911, transcript variant X2
uncharacterized LOC105683911, transcript variant X19
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: uncharacterized protein LOC105683906
metallophosphoesterase 1, transcript variant X2
metallophosphoesterase 1, transcript variant X1
cytochrome P450 9e2-like, transcript variant X2
cytochrome P450 9e2-like, transcript variant X1
uncharacterized LOC105683899, transcript variant X2
uncharacterized LOC105683899, transcript variant X1
uncharacterized protein LOC105683899 isoform X2
uncharacterized protein LOC105683899 isoform X1
uncharacterized LOC105683899, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
solute carrier family 26 member 10-like isoform X1
glycine-rich cell wall structural protein 1.0-like
glycine-rich cell wall structural protein-like
zinc finger and SCAN domain-containing protein 10, transcript variant X2
zinc finger and SCAN domain-containing protein 10, transcript variant X1
zinc finger and SCAN domain-containing protein 10, transcript variant X3
zinc finger and SCAN domain-containing protein 10
uncharacterized LOC110116879, transcript variant X2
uncharacterized LOC110116879, transcript variant X1
uncharacterized LOC110116879, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein argonaute-2, transcript variant X2
protein argonaute-2, transcript variant X1
protein argonaute-2, transcript variant X3
39S ribosomal protein L53, mitochondrial
proteasomal ubiquitin receptor ADRM1 homolog, transcript variant X3
proteasomal ubiquitin receptor ADRM1 homolog, transcript variant X4
proteasomal ubiquitin receptor ADRM1 homolog, transcript variant X2
proteasomal ubiquitin receptor ADRM1 homolog, transcript variant X1
proteasomal ubiquitin receptor ADRM1 isoform X3
proteasomal ubiquitin receptor ADRM1 homolog isoform X4
proteasomal ubiquitin receptor ADRM1 homolog isoform X2
proteasomal ubiquitin receptor ADRM1 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC105683921, transcript variant X4
uncharacterized protein LOC105683921 isoform X4
uncharacterized LOC105683921, transcript variant X6
uncharacterized LOC105683921, transcript variant X1
uncharacterized LOC105683921, transcript variant X2
uncharacterized protein LOC105683921 isoform X1
uncharacterized protein LOC105683921 isoform X2
uncharacterized LOC105683921, transcript variant X5
uncharacterized protein LOC105683921 isoform X5
uncharacterized LOC105683921, transcript variant X3
uncharacterized protein LOC105683921 isoform X3
uncharacterized protein LOC105683921 isoform X6
DNA-directed RNA polymerases I, II, and III subunit RPABC4
threonylcarbamoyladenosine tRNA methylthiotransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125502130, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
uncharacterized LOC125502130, transcript variant X2
uncharacterized LOC125502116, transcript variant X1
uncharacterized LOC125502116, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
inactive dipeptidyl peptidase 10, transcript variant X4
inactive dipeptidyl peptidase 10, transcript variant X5
inactive dipeptidyl peptidase 10, transcript variant X3
inactive dipeptidyl peptidase 10, transcript variant X2
inactive dipeptidyl peptidase 10, transcript variant X8
inactive dipeptidyl peptidase 10, transcript variant X1
inactive dipeptidyl peptidase 10, transcript variant X7
inactive dipeptidyl peptidase 10, transcript variant X6
inactive dipeptidyl peptidase 10, transcript variant X9
inactive dipeptidyl peptidase 10 isoform X2
inactive dipeptidyl peptidase 10 isoform X1
inactive dipeptidyl peptidase 10 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
alpha-tocopherol transfer protein-like, transcript variant X2
alpha-tocopherol transfer protein-like, transcript variant X3
alpha-tocopherol transfer protein-like, transcript variant X1
alpha-tocopherol transfer protein-like isoform X1
alpha-tocopherol transfer protein-like isoform X2
alpha-tocopherol transfer protein, transcript variant X1
alpha-tocopherol transfer protein, transcript variant X2
palmitoyltransferase ZDHHC5-A, transcript variant X1
uncharacterized protein LOC105692402 isoform X1
palmitoyltransferase ZDHHC5-A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
palmitoyltransferase ZDHHC5-A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
palmitoyltransferase ZDHHC5-A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
uncharacterized protein LOC105692402 isoform X2
palmitoyltransferase ZDHHC5-A isoform X3
chitin deacetylase 1, transcript variant X1
chitin deacetylase 1, transcript variant X2
prolactin regulatory element-binding protein
uncharacterized LOC125502002, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125502002, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC105692413, transcript variant X1
uncharacterized LOC105692413, transcript variant X2
uncharacterized protein LOC105692413 isoform X1
uncharacterized protein LOC105692413 isoform X2
U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 1
uncharacterized LOC105692384, transcript variant X3
uncharacterized LOC105692384, transcript variant X1
uncharacterized LOC105692384, transcript variant X2
uncharacterized protein LOC105692384 isoform X3
uncharacterized protein LOC105692384 isoform X1
uncharacterized protein LOC105692384 isoform X2
uncharacterized LOC125502071, transcript variant X2
uncharacterized LOC125502071, transcript variant X1
MAGUK p55 subfamily member 7, transcript variant X2
MAGUK p55 subfamily member 7, transcript variant X6
MAGUK p55 subfamily member 7, transcript variant X4
MAGUK p55 subfamily member 7, transcript variant X5
MAGUK p55 subfamily member 7, transcript variant X3
MAGUK p55 subfamily member 7, transcript variant X1
protein bric-a-brac 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
protein bric-a-brac 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
protein bric-a-brac 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
protein bric-a-brac 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
protein bric-a-brac 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
protein bric-a-brac 1-like, transcript variant X7
protein bric-a-brac 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
rho guanine nucleotide exchange factor 40-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: rho guanine nucleotide exchange factor 40-like
uncharacterized LOC125502123, transcript variant X2
uncharacterized LOC125502123, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transcriptional repressor CTCFL, transcript variant X5
transcriptional repressor CTCFL, transcript variant X6
transcriptional repressor CTCFL, transcript variant X8
transcriptional repressor CTCFL, transcript variant X2
transcriptional repressor CTCFL, transcript variant X1
transcriptional repressor CTCFL, transcript variant X7
transcriptional repressor CTCFL, transcript variant X3
transcriptional repressor CTCFL, transcript variant X4
transcriptional repressor CTCFL isoform X2
transcriptional repressor CTCFL isoform X5
transcriptional repressor CTCFL isoform X3
transcriptional repressor CTCFL isoform X4
transcriptional repressor CTCFL isoform X1
motile sperm domain-containing protein 2-like, transcript variant X1
motile sperm domain-containing protein 2-like, transcript variant X2
motile sperm domain-containing protein 2-like isoform X1
motile sperm domain-containing protein 2-like isoform X2
lysophosphatidic acid receptor 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
lysophosphatidic acid receptor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
lysophosphatidic acid receptor 1-like, transcript variant X4
lysophosphatidic acid receptor 1-like, transcript variant X2
uncharacterized LOC105692396, transcript variant X4
mitochondrial DNA helicase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
mitochondrial DNA helicase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1
uncharacterized LOC105692396, transcript variant X2
uncharacterized LOC105692396, transcript variant X3
uncharacterized LOC105692396, transcript variant X1
uncharacterized protein LOC105692396 isoform X1
uncharacterized protein LOC105692396 isoform X2
uncharacterized protein LOC105692396 isoform X3
uncharacterized protein LOC105692396 isoform X4
uncharacterized LOC105692389, transcript variant X4
uncharacterized LOC105692389, transcript variant X1
uncharacterized LOC105692389, transcript variant X5
uncharacterized LOC105692389, transcript variant X3
uncharacterized LOC105692389, transcript variant X2
uncharacterized LOC105692415, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1
uncharacterized LOC105692415, transcript variant X3
uncharacterized LOC105692415, transcript variant X1
twisted gastrulation protein homolog 1-A-like; Derived by automated computational analysis using gene prediction method: BestRefSeq,Gnomon.
twisted gastrulation protein homolog 1-A-like, transcript variant X2
twisted gastrulation protein homolog 1-A-like, transcript variant X1
twisted gastrulation protein homolog 1-A-like, transcript variant X6
twisted gastrulation protein homolog 1-A-like, transcript variant X3
twisted gastrulation protein homolog 1-A-like, transcript variant X5
twisted gastrulation protein homolog 1-A-like, transcript variant X4
twisted gastrulation protein homolog 1-A-like
similar to RNA sequence, mRNA (same species):RefSeq:NM_001308547.1
annotated by transcript or proteomic data
The RefSeq transcript has 3 substitutions compared to this genomic sequence; Derived by automated computational analysis using gene prediction method: BestRefSeq.
twisted gastrulation protein homolog 1-A-like isoform X1
Derived by automated computational analysis using gene prediction method: BestRefSeq.
twisted gastrulation protein homolog 1-A-like precursor
COORDINATES: ab initio prediction:SignalP:4.0
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase isozyme L3
eukaryotic translation initiation factor 3 subunit I
dendritic arbor reduction protein 1, transcript variant X4
dendritic arbor reduction protein 1, transcript variant X1
dendritic arbor reduction protein 1, transcript variant X3
dendritic arbor reduction protein 1, transcript variant X2
putative uncharacterized protein DDB_G0277255 isoform X1
putative uncharacterized protein DDB_G0277255 isoform X3
dendritic arbor reduction protein 1 isoform X2
proton-coupled amino acid transporter 1, transcript variant X2
proton-coupled amino acid transporter 1, transcript variant X1
proton-coupled amino acid transporter 1 isoform X1
differentially expressed in FDCP 8 homolog, transcript variant X2
proton-coupled amino acid transporter 1 isoform X2
differentially expressed in FDCP 8 homolog, transcript variant X3
differentially expressed in FDCP 8 homolog, transcript variant X1
differentially expressed in FDCP 8 homolog, transcript variant X5
differentially expressed in FDCP 8 homolog, transcript variant X4
differentially expressed in FDCP 8 homolog isoform X4
differentially expressed in FDCP 8 homolog isoform X3
differentially expressed in FDCP 8 homolog isoform X2
differentially expressed in FDCP 8 homolog isoform X1
gastrulation defective protein 1 homolog
exonuclease mut-7 homolog, transcript variant X3
exonuclease mut-7 homolog, transcript variant X2
exonuclease mut-7 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC105688183, transcript variant X1
uncharacterized LOC105688183, transcript variant X3
uncharacterized LOC105688183, transcript variant X2
uncharacterized LOC105688183, transcript variant X4
ras-associated and pleckstrin homology domains-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC105688136, transcript variant X7
uncharacterized LOC105688136, transcript variant X8
uncharacterized LOC105688136, transcript variant X5
uncharacterized LOC105688136, transcript variant X3
uncharacterized LOC105688136, transcript variant X4
uncharacterized LOC105688136, transcript variant X6
uncharacterized LOC105688136, transcript variant X1
uncharacterized LOC105688136, transcript variant X2
uncharacterized protein LOC105688136 isoform X3
uncharacterized protein LOC105688136 isoform X2
uncharacterized protein LOC105688136 isoform X1
uncharacterized protein LOC105688136 isoform X4
linear gramicidin synthase subunit C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
probable G-protein coupled receptor B0563.6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
putative RNA polymerase II subunit B1 CTD phosphatase RPAP2, transcript variant X2
putative RNA polymerase II subunit B1 CTD phosphatase RPAP2, transcript variant X1
putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 isoform X2
putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 isoform X1
ADP-ribosylation factor GTPase-activating protein 1, transcript variant X3
ADP-ribosylation factor GTPase-activating protein 1, transcript variant X2
ADP-ribosylation factor GTPase-activating protein 1, transcript variant X1
ADP-ribosylation factor GTPase-activating protein 1 isoform X2
ADP-ribosylation factor GTPase-activating protein 1 isoform X1
uncharacterized protein LOC105687964 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
myosin light chain kinase, smooth muscle-like, transcript variant X1
myosin light chain kinase, smooth muscle-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
myosin light chain kinase, smooth muscle-like isoform X1
myosin light chain kinase, smooth muscle-like isoform X2
uncharacterized LOC125502005, transcript variant X6
uncharacterized LOC125502005, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC125502005, transcript variant X5
uncharacterized LOC125502005, transcript variant X3
uncharacterized LOC125502005, transcript variant X4
uncharacterized LOC125502005, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
proton-coupled amino acid transporter-like protein pathetic
DNA-directed RNA polymerases I, II, and III subunit RPABC5
uncharacterized LOC125502004, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125502004, transcript variant X6
uncharacterized LOC125502004, transcript variant X7
uncharacterized LOC125502004, transcript variant X4
uncharacterized LOC125502004, transcript variant X2
uncharacterized LOC125502004, transcript variant X5
uncharacterized LOC125502004, transcript variant X3
fork head domain-containing protein crocodile
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized LOC125502004, transcript variant X1
adenylate cyclase type 2-like, transcript variant X2
adenylate cyclase type 2-like isoform X2
adenylate cyclase type 2-like, transcript variant X3
adenylate cyclase type 2-like, transcript variant X1
adenylate cyclase type 2-like isoform X1
adenylate cyclase type 2-like isoform X3
adenylate cyclase type 2-like, transcript variant X4
adenylate cyclase type 2-like isoform X4
E3 ubiquitin-protein ligase MYCBP2, transcript variant X1
E3 ubiquitin-protein ligase MYCBP2, transcript variant X2
E3 ubiquitin-protein ligase MYCBP2, transcript variant X4
E3 ubiquitin-protein ligase MYCBP2, transcript variant X3
E3 ubiquitin-protein ligase MYCBP2, transcript variant X5
E3 ubiquitin-protein ligase MYCBP2 isoform X1
E3 ubiquitin-protein ligase MYCBP2 isoform X2
E3 ubiquitin-protein ligase MYCBP2 isoform X4
E3 ubiquitin-protein ligase MYCBP2 isoform X3
E3 ubiquitin-protein ligase MYCBP2 isoform X5
uncharacterized LOC105688077, transcript variant X5
uncharacterized LOC105688077, transcript variant X2
uncharacterized LOC105688077, transcript variant X4
uncharacterized LOC105688077, transcript variant X1
uncharacterized LOC105688077, transcript variant X3
uncharacterized protein LOC105688077 isoform X2
uncharacterized protein LOC105688077 isoform X1
uncharacterized protein LOC105688077 isoform X3
WD repeat-containing protein 47, transcript variant X4
WD repeat-containing protein 47, transcript variant X2
WD repeat-containing protein 47 isoform X2
WD repeat-containing protein 47, transcript variant X1
WD repeat-containing protein 47, transcript variant X3
WD repeat-containing protein 47 isoform X1
WD repeat-containing protein 47 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
WD repeat-containing protein 47 isoform X4
zinc finger protein 362, transcript variant X2
zinc finger protein 362, transcript variant X1
zinc finger protein 362, transcript variant X3
heat shock 70 kDa protein cognate 4-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 267 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
heat shock 70 kDa protein cognate 4-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 267 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
heat shock 70 kDa protein cognate 4-like, transcript variant X3
heat shock 70 kDa protein cognate 4-like, transcript variant X10
heat shock 70 kDa protein cognate 4-like, transcript variant X8
heat shock 70 kDa protein cognate 4-like, transcript variant X4
heat shock 70 kDa protein cognate 4-like, transcript variant X1
heat shock 70 kDa protein cognate 4-like, transcript variant X11
heat shock 70 kDa protein cognate 4-like, transcript variant X2
heat shock 70 kDa protein cognate 4-like, transcript variant X9
heat shock 70 kDa protein cognate 4-like, transcript variant X6
heat shock 70 kDa protein cognate 4-like isoform X2
heat shock 70 kDa protein cognate 4-like isoform X1
heat shock 70 kDa protein-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat extensin-like protein 5, transcript variant X4
leucine-rich repeat extensin-like protein 5 isoform X2
leucine-rich repeat extensin-like protein 5, transcript variant X1
leucine-rich repeat extensin-like protein 5, transcript variant X3
leucine-rich repeat extensin-like protein 5, transcript variant X2
leucine-rich repeat extensin-like protein 5 isoform X1
leucine-rich repeat-containing protein 15-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
myogenesis-regulating glycosidase-like, transcript variant X1
myogenesis-regulating glycosidase-like, transcript variant X2
myogenesis-regulating glycosidase-like isoform X1
myogenesis-regulating glycosidase-like isoform X2
gastrula zinc finger protein XlCGF57.1-like
mediator of RNA polymerase II transcription subunit 23
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X5
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X2
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X4
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X1
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X6
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X8
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X3
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein isoform X1
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein isoform X2
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein isoform X4
carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein, transcript variant X7
transmembrane channel-like protein, transcript variant X2
transmembrane channel-like protein, transcript variant X1
transmembrane channel-like protein, transcript variant X3
transmembrane channel-like protein isoform X1
transmembrane channel-like protein isoform X2
transmembrane channel-like protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC105691043, transcript variant X3
uncharacterized LOC105691043, transcript variant X2
uncharacterized LOC105691043, transcript variant X6
uncharacterized LOC105691043, transcript variant X5
uncharacterized LOC105691043, transcript variant X4
uncharacterized LOC105691043, transcript variant X8
uncharacterized LOC105691043, transcript variant X7
uncharacterized LOC105691043, transcript variant X9
uncharacterized LOC105691043, transcript variant X1
uncharacterized LOC105691043, transcript variant X10
uncharacterized LOC105691043, transcript variant X11
uncharacterized protein LOC105691043 isoform X2
uncharacterized protein LOC105691043 isoform X1
uncharacterized protein LOC105691043 isoform X3
uncharacterized protein LOC105691043 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
L-lactate dehydrogenase A-like 6A, transcript variant X1
L-lactate dehydrogenase A-like 6A, transcript variant X3
L-lactate dehydrogenase A-like 6A, transcript variant X2
L-lactate dehydrogenase A-like 6A, transcript variant X4
L-lactate dehydrogenase A-like 6A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
L-lactate dehydrogenase A-like 6A isoform X1
L-lactate dehydrogenase A-like 6A isoform X3
L-lactate dehydrogenase A-like 6A isoform X2
L-lactate dehydrogenase A-like 6A isoform X4
L-lactate dehydrogenase A-like 6A isoform X5
L-lactate dehydrogenase-like, transcript variant X3
L-lactate dehydrogenase-like, transcript variant X1
L-lactate dehydrogenase-like, transcript variant X2
L-lactate dehydrogenase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC105684499, transcript variant X1
uncharacterized LOC105684499, transcript variant X2
uncharacterized protein LOC105684499 isoform X1
uncharacterized protein LOC105684499 isoform X2
uncharacterized LOC105684530, transcript variant X2
uncharacterized LOC105684530, transcript variant X1
uncharacterized protein LOC105684530 isoform X1
uncharacterized protein LOC105684530 isoform X2
uncharacterized LOC125502053, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC125502053, transcript variant X3
uncharacterized LOC125502053, transcript variant X2
three-prime repair exonuclease 1, transcript variant X4
three-prime repair exonuclease 1, transcript variant X2
three-prime repair exonuclease 1, transcript variant X3
three-prime repair exonuclease 1, transcript variant X1
three-prime repair exonuclease 1 isoform X4
three-prime repair exonuclease 1 isoform X2
uncharacterized protein LOC105693072 isoform X3
three-prime repair exonuclease 1 isoform X1
serine/threonine-protein kinase N, transcript variant X3
serine/threonine-protein kinase N, transcript variant X2
serine/threonine-protein kinase N, transcript variant X1
serine/threonine-protein kinase N, transcript variant X4
serine/threonine-protein kinase N isoform X3
serine/threonine-protein kinase N isoform X4
serine/threonine-protein kinase N isoform X2
serine/threonine-protein kinase N isoform X1
conserved oligomeric Golgi complex subunit 6, transcript variant X1
conserved oligomeric Golgi complex subunit 6, transcript variant X2
conserved oligomeric Golgi complex subunit 6 isoform X1
conserved oligomeric Golgi complex subunit 6 isoform X2
ankyrin repeat domain-containing protein SOWAHB, transcript variant X4
ankyrin repeat domain-containing protein SOWAHB, transcript variant X3
ankyrin repeat domain-containing protein SOWAHB, transcript variant X5
ankyrin repeat domain-containing protein SOWAHB, transcript variant X2
ankyrin repeat domain-containing protein SOWAHB, transcript variant X1
ankyrin repeat domain-containing protein SOWAHB isoform X5
ankyrin repeat domain-containing protein SOWAHC isoform X4
ankyrin repeat domain-containing protein SOWAHC isoform X2
ankyrin repeat domain-containing protein SOWAHC isoform X3
ankyrin repeat domain-containing protein SOWAHC isoform X1
ankyrin repeat domain-containing protein SOWAHB, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
homeobox protein araucan, transcript variant X1
homeobox protein araucan, transcript variant X2
homeobox protein araucan, transcript variant X3
homeobox protein araucan, transcript variant X5
homeobox protein araucan, transcript variant X4
homeobox protein araucan, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
homeobox protein caupolican, transcript variant X2
homeobox protein caupolican, transcript variant X1
N-acetylgalactosamine kinase, transcript variant X1
N-acetylgalactosamine kinase, transcript variant X5
N-acetylgalactosamine kinase, transcript variant X3
N-acetylgalactosamine kinase, transcript variant X4
N-acetylgalactosamine kinase, transcript variant X2
uncharacterized LOC105684968, transcript variant X1
uncharacterized LOC105684968, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 35-like, transcript variant X6
ubiquitin carboxyl-terminal hydrolase 35-like, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 35-like, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 35-like, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 35-like, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 35-like, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 35-like
dosage compensation regulator, transcript variant X1
dosage compensation regulator isoform X1
dosage compensation regulator, transcript variant X2
dosage compensation regulator isoform X2
dosage compensation regulator, transcript variant X3
dosage compensation regulator isoform X3
JNK-interacting protein 3, transcript variant X1
JNK-interacting protein 3, transcript variant X2
JNK-interacting protein 3, transcript variant X3
JNK-interacting protein 3, transcript variant X5
JNK-interacting protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X9
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X13
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X12
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X10
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X9
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X8
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X6
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X7
coiled-coil domain-containing protein 93, transcript variant X2
coiled-coil domain-containing protein 93, transcript variant X1
coiled-coil domain-containing protein 93 isoform X2
coiled-coil domain-containing protein 93 isoform X1
SET and MYND domain-containing protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
SET and MYND domain-containing protein 4-like, transcript variant X1
SET and MYND domain-containing protein 4-like
UNC93-like protein, transcript variant X2
UNC93-like protein, transcript variant X1
leucine-rich repeat protein soc-2 homolog
ras-specific guanine nucleotide-releasing factor RalGPS2, transcript variant X6
ras-specific guanine nucleotide-releasing factor RalGPS2, transcript variant X7
ras-specific guanine nucleotide-releasing factor RalGPS2, transcript variant X5
ras-specific guanine nucleotide-releasing factor RalGPS2, transcript variant X1
ras-specific guanine nucleotide-releasing factor RalGPS2, transcript variant X4
ras-specific guanine nucleotide-releasing factor RalGPS2, transcript variant X2
ras-specific guanine nucleotide-releasing factor RalGPS2, transcript variant X3
uncharacterized LOC125501998, transcript variant X5
uncharacterized LOC125501998, transcript variant X2
uncharacterized LOC125501998, transcript variant X3
uncharacterized LOC125501998, transcript variant X6
uncharacterized LOC125501998, transcript variant X1
uncharacterized LOC125501998, transcript variant X4
ras-specific guanine nucleotide-releasing factor RalGPS2 isoform X5
ras-specific guanine nucleotide-releasing factor RalGPS2 isoform X1
ras-specific guanine nucleotide-releasing factor RalGPS2 isoform X4
ras-specific guanine nucleotide-releasing factor RalGPS2 isoform X2
ras-specific guanine nucleotide-releasing factor RalGPS2 isoform X3
ras-specific guanine nucleotide-releasing factor RalGPS2, transcript variant X8
ras-specific guanine nucleotide-releasing factor RalGPS2 isoform X6
inhibitory POU protein, transcript variant X6
inhibitory POU protein, transcript variant X3
inhibitory POU protein, transcript variant X4
inhibitory POU protein, transcript variant X5
inhibitory POU protein, transcript variant X7
inhibitory POU protein, transcript variant X10
inhibitory POU protein, transcript variant X8
inhibitory POU protein, transcript variant X9
inhibitory POU protein, transcript variant X2
inhibitory POU protein, transcript variant X1
zinc finger and SCAN domain-containing protein 22-like, transcript variant X1
zinc finger and SCAN domain-containing protein 22-like, transcript variant X2
zinc finger and SCAN domain-containing protein 22-like isoform X1
zinc finger and SCAN domain-containing protein 22-like isoform X2
uncharacterized LOC105684996, transcript variant X1
uncharacterized LOC105684996, transcript variant X2
uncharacterized LOC105684996, transcript variant X3
uncharacterized protein LOC105684996 isoform X1
uncharacterized protein LOC105684996 isoform X2
uncharacterized protein LOC105684996 isoform X3
abasic site processing protein HMCES, transcript variant X1
abasic site processing protein HMCES isoform X1
abasic site processing protein HMCES, transcript variant X2
abasic site processing protein HMCES isoform X2
abasic site processing protein HMCES, transcript variant X3
abasic site processing protein HMCES isoform X3
tyrosine-protein phosphatase non-receptor type 2, transcript variant X1
tyrosine-protein phosphatase non-receptor type 2, transcript variant X3
tyrosine-protein phosphatase non-receptor type 2, transcript variant X2
tyrosine-protein phosphatase non-receptor type 2 isoform X3
tyrosine-protein phosphatase non-receptor type 2 isoform X1
tyrosine-protein phosphatase non-receptor type 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
RING finger and SPRY domain-containing protein 1-like
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X2
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X1
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X2
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X3
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X3
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X5
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X6
uncharacterized LOC125501997, transcript variant X2
uncharacterized LOC125501997, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X4
serine/threonine-protein phosphatase 4 regulatory subunit 1-like, transcript variant X7
serine/threonine-protein phosphatase 4 regulatory subunit 1-like isoform X4
uncharacterized LOC105684989, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC105684989, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized protein LOC105684989 isoform X1
uncharacterized protein LOC105684989 isoform X2
SPARC-related modular calcium-binding protein 2, transcript variant X1
SPARC-related modular calcium-binding protein 2, transcript variant X3
SPARC-related modular calcium-binding protein 2, transcript variant X2
SPARC-related modular calcium-binding protein 2, transcript variant X4
SPARC-related modular calcium-binding protein 2 isoform X1
SPARC-related modular calcium-binding protein 2 isoform X2
SPARC-related modular calcium-binding protein 2 isoform X3
SPARC-related modular calcium-binding protein 2 isoform X4
uncharacterized LOC105684979, transcript variant X3
uncharacterized LOC105684979, transcript variant X4
uncharacterized LOC105684979, transcript variant X1
uncharacterized LOC105684979, transcript variant X2
uncharacterized LOC105684979, transcript variant X5
uncharacterized protein LOC105684979 isoform X1
uncharacterized protein LOC105684979 isoform X2
polyisoprenoid diphosphate/phosphate phosphohydrolase PLPP6
probable cytochrome P450 4aa1, transcript variant X1
probable cytochrome P450 4aa1 isoform X1
probable cytochrome P450 4aa1, transcript variant X2
probable cytochrome P450 4aa1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
NAD-dependent protein deacetylase sirtuin-7, transcript variant X2
NAD-dependent protein deacetylase sirtuin-7, transcript variant X1
NAD-dependent protein deacetylase sirtuin-7
histone-arginine methyltransferase METTL23-like
SRA stem-loop-interacting RNA-binding protein, mitochondrial
acyl-CoA-binding domain-containing protein 6
rho GTPase-activating protein 44-like, transcript variant X2
rho GTPase-activating protein 44-like, transcript variant X1
rho GTPase-activating protein 44-like isoform X2
rho GTPase-activating protein 44-like isoform X1
uncharacterized LOC105693261, transcript variant X1
uncharacterized LOC105693261, transcript variant X4
uncharacterized LOC105693261, transcript variant X5
uncharacterized LOC105693261, transcript variant X3
uncharacterized LOC105693261, transcript variant X2
uncharacterized LOC110117450, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC110117450, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
BMP and activin membrane-bound inhibitor homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BMP and activin membrane-bound inhibitor homolog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
BMP and activin membrane-bound inhibitor homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
BMP and activin membrane-bound inhibitor homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
BMP and activin membrane-bound inhibitor homolog, transcript variant X1
BMP and activin membrane-bound inhibitor homolog, transcript variant X7
uncharacterized protein LOC105693260 isoform X1
BMP and activin membrane-bound inhibitor homolog isoform X3
BMP and activin membrane-bound inhibitor homolog, transcript variant X9
BMP and activin membrane-bound inhibitor homolog, transcript variant X6
BMP and activin membrane-bound inhibitor homolog isoform X2
BMP and activin membrane-bound inhibitor homolog, transcript variant X10
BMP and activin membrane-bound inhibitor homolog, transcript variant X8
BMP and activin membrane-bound inhibitor homolog isoform X5
BMP and activin membrane-bound inhibitor homolog isoform X4
CTD nuclear envelope phosphatase 1 homolog, transcript variant X1
CTD nuclear envelope phosphatase 1 homolog, transcript variant X2
CTD nuclear envelope phosphatase 1 homolog isoform X1
CTD nuclear envelope phosphatase 1 homolog isoform X2
AP-2 complex subunit mu, transcript variant X1
AP-2 complex subunit mu, transcript variant X2
DCN1-like protein 3, transcript variant X2
DCN1-like protein 3, transcript variant X1
coiled-coil domain-containing protein 40, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
coiled-coil domain-containing protein 40, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
coiled-coil domain-containing protein 40
eukaryotic peptide chain release factor GTP-binding subunit ERF3A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
intraflagellar transport protein 122 homolog, transcript variant X1
intraflagellar transport protein 122 homolog, transcript variant X2
intraflagellar transport protein 122 homolog isoform X1
intraflagellar transport protein 122 homolog isoform X2
kelch domain-containing protein 4, transcript variant X2
kelch domain-containing protein 4, transcript variant X1
kelch domain-containing protein 4 isoform X1
kelch domain-containing protein 4 isoform X2
valine--tRNA ligase-like, transcript variant X2
valine--tRNA ligase-like, transcript variant X1
uncharacterized protein C1orf112 homolog, transcript variant X1
uncharacterized protein C1orf112 homolog, transcript variant X2
uncharacterized protein C1orf112 homolog isoform X1
uncharacterized protein C1orf112 homolog, transcript variant X3
uncharacterized protein LOC105693257 isoform X2
E3 ubiquitin-protein ligase LRSAM1-like, transcript variant X1
E3 ubiquitin-protein ligase LRSAM1-like, transcript variant X2
E3 ubiquitin-protein ligase LRSAM1-like isoform X1
E3 ubiquitin-protein ligase LRSAM1-like isoform X2
E3 ubiquitin-protein ligase LRSAM1-like, transcript variant X3
E3 ubiquitin-protein ligase LRSAM1-like isoform X3
DNA polymerase epsilon subunit 3, transcript variant X1
DNA polymerase epsilon subunit 3, transcript variant X2
gamma-soluble NSF attachment protein-like, transcript variant X2
gamma-soluble NSF attachment protein-like, transcript variant X1
gamma-soluble NSF attachment protein-like isoform X1
gamma-soluble NSF attachment protein-like isoform X2
laminin subunit gamma-1, transcript variant X1
laminin subunit gamma-1, transcript variant X2
laminin subunit gamma-1, transcript variant X5
laminin subunit gamma-1, transcript variant X4
laminin subunit gamma-1, transcript variant X3
rhythmically expressed gene 2 protein-like
SIN3-HDAC complex-associated factor, transcript variant X1
SIN3-HDAC complex-associated factor, transcript variant X2
rho GTPase-activating protein 1, transcript variant X2
rho GTPase-activating protein 1, transcript variant X1
rho GTPase-activating protein 1 isoform X2
rho GTPase-activating protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC105693255, transcript variant X1
uncharacterized LOC105693255, transcript variant X3
uncharacterized LOC105693255, transcript variant X2
uncharacterized protein LOC105693255 isoform X1
uncharacterized protein LOC105693255 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC105693293, transcript variant X1
uncharacterized LOC105693293, transcript variant X2
uncharacterized protein LOC105693293 isoform X1
uncharacterized protein LOC105693293 isoform X2
prohormone-1-like, transcript variant X1
prohormone-1-like, transcript variant X3
prohormone-1-like, transcript variant X2
serine/threonine-protein kinase VRK1-like
ribosome quality control complex subunit NEMF homolog
zinc finger CCCH domain-containing protein 13, transcript variant X4
zinc finger CCCH domain-containing protein 13, transcript variant X2
zinc finger CCCH domain-containing protein 13, transcript variant X5
zinc finger CCCH domain-containing protein 13, transcript variant X3
zinc finger CCCH domain-containing protein 13, transcript variant X1
zinc finger CCCH domain-containing protein 13 isoform X3
zinc finger CCCH domain-containing protein 13 isoform X2
zinc finger CCCH domain-containing protein 13 isoform X5
zinc finger CCCH domain-containing protein 13 isoform X1
zinc finger CCCH domain-containing protein 13 isoform X4
26S proteasome non-ATPase regulatory subunit 11
transformer-2 protein homolog alpha, transcript variant X2
transformer-2 protein homolog alpha, transcript variant X1
transformer-2 protein homolog alpha, transcript variant X3
transformer-2 protein homolog alpha isoform X1
transformer-2 protein homolog alpha isoform X3
transformer-2 protein homolog alpha isoform X2
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X2
biogenesis of lysosome-related organelles complex 1 subunit 1, transcript variant X1
biogenesis of lysosome-related organelles complex 1 subunit 1
serine/threonine-protein kinase/endoribonuclease IRE1
ankyrin repeat domain-containing protein 27-like
splicing factor U2AF 50 kDa subunit, transcript variant X1
splicing factor U2AF 50 kDa subunit isoform X1
splicing factor U2AF 50 kDa subunit, transcript variant X2
splicing factor U2AF 50 kDa subunit isoform X2
uncharacterized LOC105686153, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC105686153, transcript variant X1
uncharacterized protein LOC105686153 isoform X2
uncharacterized protein LOC105686153 isoform X1
cytosolic endo-beta-N-acetylglucosaminidase
uncharacterized LOC105686624, transcript variant X1
uncharacterized LOC105686624, transcript variant X3
uncharacterized LOC105686624, transcript variant X2
uncharacterized protein LOC105686624 isoform X1
uncharacterized protein LOC105686624 isoform X3
uncharacterized protein LOC105686624 isoform X2
serine-threonine kinase receptor-associated protein, transcript variant X2
serine-threonine kinase receptor-associated protein, transcript variant X3
serine-threonine kinase receptor-associated protein, transcript variant X1
serine-threonine kinase receptor-associated protein isoform X1
serine-threonine kinase receptor-associated protein isoform X2
peptidyl-tRNA hydrolase ICT1, mitochondrial, transcript variant X1
peptidyl-tRNA hydrolase ICT1, mitochondrial, transcript variant X2
peptidyl-tRNA hydrolase ICT1, mitochondrial, transcript variant X3
peptidyl-tRNA hydrolase ICT1, mitochondrial isoform X1
peptidyl-tRNA hydrolase ICT1, mitochondrial isoform X2
peptidyl-tRNA hydrolase ICT1, mitochondrial, transcript variant X4
peptidyl-tRNA hydrolase ICT1, mitochondrial isoform X3
clusterin-associated protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
clusterin-associated protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
clusterin-associated protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
clusterin-associated protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
clusterin-associated protein 1, transcript variant X1
sodium-independent sulfate anion transporter-like, transcript variant X2
sodium-independent sulfate anion transporter-like, transcript variant X5
sodium-independent sulfate anion transporter-like, transcript variant X1
sodium-independent sulfate anion transporter-like, transcript variant X4
sodium-independent sulfate anion transporter-like, transcript variant X3
sodium-independent sulfate anion transporter-like isoform X4
sodium-independent sulfate anion transporter-like isoform X5
sodium-independent sulfate anion transporter-like isoform X2
probable sulfate permease C3H7.02 isoform X1
sodium-independent sulfate anion transporter-like isoform X3
sodium-independent sulfate anion transporter-like, transcript variant X7
sodium-independent sulfate anion transporter-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon GCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon AGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
sodium-independent sulfate anion transporter-like
galactokinase-like, transcript variant X3
galactokinase-like, transcript variant X1
galactokinase-like, transcript variant X2
uncharacterized LOC105686328, transcript variant X5
uncharacterized LOC105686328, transcript variant X3
uncharacterized protein LOC105686328 isoform X3
uncharacterized LOC105686328, transcript variant X1
uncharacterized LOC105686328, transcript variant X2
uncharacterized protein LOC105686328 isoform X1
uncharacterized protein LOC105686328 isoform X2
uncharacterized LOC105686328, transcript variant X4
uncharacterized protein LOC105686328 isoform X4
(E3-independent) E2 ubiquitin-conjugating enzyme, transcript variant X1
(E3-independent) E2 ubiquitin-conjugating enzyme, transcript variant X2
(E3-independent) E2 ubiquitin-conjugating enzyme isoform X1
(E3-independent) E2 ubiquitin-conjugating enzyme isoform X2
isopentenyl-diphosphate Delta-isomerase 1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, transcript variant X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B, transcript variant X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B isoform X1
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B isoform X2
uncharacterized LOC105686327, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC105686327, transcript variant X1
uncharacterized LOC110117035, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC110117035, transcript variant X2
putative RNA-binding protein Luc7-like 2, transcript variant X1
putative RNA-binding protein Luc7-like 2 isoform X1
putative RNA-binding protein Luc7-like 2, transcript variant X4
putative RNA-binding protein Luc7-like 2, transcript variant X3
putative RNA-binding protein Luc7-like 2, transcript variant X2
putative RNA-binding protein Luc7-like 1 isoform X2
uncharacterized LOC105686257, transcript variant X1
uncharacterized LOC105686257, transcript variant X2
uncharacterized LOC105686257, transcript variant X6
uncharacterized LOC105686257, transcript variant X4
uncharacterized LOC105686257, transcript variant X5
uncharacterized LOC105686257, transcript variant X3
uncharacterized protein LOC105686257 isoform X1
uncharacterized protein LOC105686257 isoform X2
uncharacterized protein LOC105686257 isoform X3
transcriptional protein SWT1, transcript variant X3
transcriptional protein SWT1, transcript variant X2
transcriptional protein SWT1, transcript variant X1
transcriptional protein SWT1, transcript variant X4
serine protease snake-like, transcript variant X2
serine protease snake-like, transcript variant X1
tyrosine-protein phosphatase non-receptor type 14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
uncharacterized LOC105686248, transcript variant X1
uncharacterized LOC105686248, transcript variant X2
uncharacterized LOC105686248, transcript variant X4
uncharacterized LOC105686248, transcript variant X3
breast cancer metastasis-suppressor 1-like protein, transcript variant X2
breast cancer metastasis-suppressor 1-like protein, transcript variant X1
breast cancer metastasis-suppressor 1-like protein, transcript variant X3
breast cancer metastasis-suppressor 1-like protein isoform X1
breast cancer metastasis-suppressor 1-like protein isoform X2
G-protein coupled receptor moody, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
G-protein coupled receptor moody, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
G-protein coupled receptor moody isoform X2
G-protein coupled receptor moody, transcript variant X5
G-protein coupled receptor moody, transcript variant X1
G-protein coupled receptor moody, transcript variant X3
G-protein coupled receptor moody, transcript variant X4
G-protein coupled receptor moody isoform X1
G-protein coupled receptor moody isoform X3
uncharacterized protein LOC105686273 isoform X4
uncharacterized LOC110117018, transcript variant X2
uncharacterized LOC110117018, transcript variant X1
uncharacterized protein LOC110117018 isoform X2
uncharacterized protein LOC110117018 isoform X1
G patch domain-containing protein 2, transcript variant X2
G patch domain-containing protein 2, transcript variant X1
G patch domain-containing protein 2, transcript variant X3
mitochondrial import inner membrane translocase subunit Tim9
fumarate hydratase, mitochondrial-like, transcript variant X1
fumarate hydratase, mitochondrial-like, transcript variant X2
fumarate hydratase, mitochondrial-like isoform X1
fumarate hydratase, mitochondrial-like isoform X2
acyl-CoA:lysophosphatidylglycerol acyltransferase 1-like, transcript variant X1
acyl-CoA:lysophosphatidylglycerol acyltransferase 1-like isoform X1
acyl-CoA:lysophosphatidylglycerol acyltransferase 1-like, transcript variant X2
acyl-CoA:lysophosphatidylglycerol acyltransferase 1-like isoform X2
DNA-directed RNA polymerase II subunit RPB3, transcript variant X1
DNA-directed RNA polymerase II subunit RPB3, transcript variant X2
DNA-directed RNA polymerase II subunit RPB3 isoform X1
DNA-directed RNA polymerase II subunit RPB3 isoform X2
structural maintenance of chromosomes protein 3
probable histone-lysine N-methyltransferase CG1716, transcript variant X1
probable histone-lysine N-methyltransferase CG1716, transcript variant X2
probable histone-lysine N-methyltransferase CG1716
diacylglycerol kinase eta, transcript variant X2
diacylglycerol kinase eta, transcript variant X3
diacylglycerol kinase eta, transcript variant X6
diacylglycerol kinase eta, transcript variant X1
diacylglycerol kinase eta, transcript variant X7
diacylglycerol kinase eta, transcript variant X5
diacylglycerol kinase eta, transcript variant X4
diacylglycerol kinase eta, transcript variant X8
transfer RNA threonine (anticodon CGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
diacylglycerol kinase eta, transcript variant X10
diacylglycerol kinase eta, transcript variant X9
probable glutamate--tRNA ligase, mitochondrial
pyruvate carboxylase, mitochondrial, transcript variant X1
pyruvate carboxylase, mitochondrial, transcript variant X2
pyruvate carboxylase, mitochondrial isoform X2
pyruvate carboxylase, mitochondrial isoform X1
probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial
uncharacterized LOC105686611, transcript variant X5
uncharacterized LOC105686611, transcript variant X3
uncharacterized protein LOC105686611 isoform X3
uncharacterized protein LOC105686611 isoform X5
uncharacterized LOC105686611, transcript variant X2
uncharacterized LOC105686611, transcript variant X1
uncharacterized LOC105686611, transcript variant X6
uncharacterized LOC105686611, transcript variant X8
uncharacterized protein LOC105686611 isoform X2
uncharacterized protein LOC105686611 isoform X1
uncharacterized protein LOC105686611 isoform X8
uncharacterized protein LOC105686611 isoform X6
uncharacterized LOC105686611, transcript variant X13
uncharacterized LOC105686611, transcript variant X12
uncharacterized LOC105686611, transcript variant X7
uncharacterized LOC105686611, transcript variant X9
uncharacterized protein LOC105686611 isoform X7
uncharacterized LOC105686611, transcript variant X11
uncharacterized LOC105686611, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC105686611 isoform X4
uncharacterized LOC105686611, transcript variant X14
uncharacterized LOC105686611, transcript variant X15
echinoderm microtubule-associated protein-like 2, transcript variant X1
echinoderm microtubule-associated protein-like 2, transcript variant X7
echinoderm microtubule-associated protein-like 2, transcript variant X8
echinoderm microtubule-associated protein-like 2, transcript variant X3
echinoderm microtubule-associated protein-like 2, transcript variant X2
echinoderm microtubule-associated protein-like 2, transcript variant X6
echinoderm microtubule-associated protein-like 2, transcript variant X4
echinoderm microtubule-associated protein-like 2, transcript variant X5
echinoderm microtubule-associated protein-like 2 isoform X8
echinoderm microtubule-associated protein-like 2 isoform X7
echinoderm microtubule-associated protein-like 2 isoform X3
echinoderm microtubule-associated protein-like 2 isoform X1
echinoderm microtubule-associated protein-like 2 isoform X6
echinoderm microtubule-associated protein-like 2 isoform X4
echinoderm microtubule-associated protein-like 2 isoform X2
echinoderm microtubule-associated protein-like 2 isoform X5
uncharacterized LOC105686611, transcript variant X10
uncharacterized LOC105686611, transcript variant X16
MD-2-related lipid-recognition protein-like
uncharacterized LOC105686730, transcript variant X1
uncharacterized LOC105686730, transcript variant X3
uncharacterized LOC105686730, transcript variant X5
uncharacterized LOC105686730, transcript variant X2
uncharacterized LOC105686730, transcript variant X7
uncharacterized LOC105686730, transcript variant X4
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X2
putative mediator of RNA polymerase II transcription subunit 12, transcript variant X1
putative mediator of RNA polymerase II transcription subunit 12 isoform X1
putative mediator of RNA polymerase II transcription subunit 12 isoform X2
uncharacterized LOC105686730, transcript variant X6
mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51, transcript variant X3
mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51, transcript variant X2
mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51, transcript variant X1
mitochondrial nicotinamide adenine dinucleotide transporter SLC25A51
uncharacterized LOC125502132, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125502132, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
cilia- and flagella-associated protein 20-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 24% coverage of the annotated genomic feature by RNAseq alignments
glycine-rich cell wall structural protein-like, transcript variant X1
glycine-rich cell wall structural protein-like, transcript variant X2
glycine-rich cell wall structural protein-like isoform X1
glycine-rich cell wall structural protein 1-like isoform X2
uncharacterized transmembrane protein DDB_G0289901-like, transcript variant X2
uncharacterized transmembrane protein DDB_G0289901-like, transcript variant X1
uncharacterized transmembrane protein DDB_G0289901-like isoform X2
uncharacterized transmembrane protein DDB_G0289901-like isoform X1
serrate RNA effector molecule homolog, transcript variant X1
serrate RNA effector molecule homolog, transcript variant X2
serrate RNA effector molecule homolog isoform X1
serrate RNA effector molecule homolog isoform X2
intracellular protein transport protein USO1-like
uncharacterized LOC105686673, transcript variant X5
uncharacterized LOC105686673, transcript variant X4
uncharacterized LOC105686673, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
uncharacterized LOC105686673, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
uncharacterized LOC105686673, transcript variant X3
uncharacterized protein LOC105686673 isoform X1
uncharacterized protein LOC105686673 isoform X2
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2
dynein regulatory complex subunit 2-like, transcript variant X1
dynein regulatory complex subunit 2-like isoform X1
dynein regulatory complex subunit 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dynein regulatory complex subunit 2-like isoform X2
keratin-associated protein 19-2-like, transcript variant X1
keratin-associated protein 19-2-like, transcript variant X2
maestro heat-like repeat-containing protein family member 1, transcript variant X1
maestro heat-like repeat-containing protein family member 1, transcript variant X2
maestro heat-like repeat-containing protein family member 1 isoform X1
maestro heat-like repeat-containing protein family member 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain-containing protein 28B, transcript variant X4
coiled-coil domain-containing protein 28B, transcript variant X1
coiled-coil domain-containing protein 28B, transcript variant X2
coiled-coil domain-containing protein 28B, transcript variant X3
coiled-coil domain-containing protein 28B isoform X2
coiled-coil domain-containing protein 28A isoform X1
E3 ubiquitin-protein ligase UBR5, transcript variant X1
E3 ubiquitin-protein ligase UBR5, transcript variant X2
E3 ubiquitin-protein ligase UBR5, transcript variant X3
E3 ubiquitin-protein ligase UBR5 isoform X1
E3 ubiquitin-protein ligase UBR5 isoform X2
E3 ubiquitin-protein ligase UBR5 isoform X3
uncharacterized LOC125502135, transcript variant X2
uncharacterized LOC125502135, transcript variant X1
esterase FE4-like, transcript variant X4
esterase FE4-like, transcript variant X1
esterase FE4-like, transcript variant X3
esterase FE4-like, transcript variant X2
uncharacterized LOC125502136, transcript variant X2
uncharacterized LOC125502136, transcript variant X1
uncharacterized LOC105686401, transcript variant X2
uncharacterized LOC105686401, transcript variant X6
uncharacterized LOC105686401, transcript variant X5
uncharacterized LOC105686401, transcript variant X3
uncharacterized LOC105686401, transcript variant X4
uncharacterized LOC105686401, transcript variant X1
tubulin polyglutamylase TTLL13-like, transcript variant X1
tubulin polyglutamylase TTLL13-like, transcript variant X2
tubulin polyglutamylase TTLL13-like, transcript variant X3
tubulin polyglutamylase TTLL13-like, transcript variant X4
tubulin polyglutamylase TTLL13-like isoform X1
tubulin polyglutamylase TTLL13-like isoform X2
tubulin polyglutamylase TTLL13-like isoform X3
tubulin polyglutamylase TTLL13-like isoform X4
nucleolar protein 6, transcript variant X1
nucleolar protein 6, transcript variant X3
nucleolar protein 6, transcript variant X4
nucleolar protein 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC125502138, transcript variant X2
uncharacterized LOC125502138, transcript variant X1
fasciculation and elongation protein zeta-2
uncharacterized LOC105686300, transcript variant X4
uncharacterized LOC105686300, transcript variant X3
uncharacterized LOC105686300, transcript variant X1
uncharacterized LOC105686300, transcript variant X2
uncharacterized protein LOC105686300 isoform X1
uncharacterized protein LOC105686300 isoform X2
probable glutamate--tRNA ligase, mitochondrial, transcript variant X8
uncharacterized protein LOC125502115 isoform X4
uncharacterized protein LOC125502115 isoform X1
probable glutamate--tRNA ligase, mitochondrial isoform X3
uncharacterized LOC125502084, transcript variant X2
uncharacterized LOC125502084, transcript variant X4
uncharacterized LOC125502084, transcript variant X3
uncharacterized LOC125502084, transcript variant X1
uncharacterized LOC125502084, transcript variant X5
sensory neuron membrane protein 1, transcript variant X2
sensory neuron membrane protein 1, transcript variant X1
sensory neuron membrane protein 1 isoform X1
sensory neuron membrane protein 1 isoform X2
uncharacterized LOC110117021, transcript variant X2
uncharacterized LOC110117021, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
arylalkylamine N-acetyltransferase 1, transcript variant X2
arylalkylamine N-acetyltransferase 1, transcript variant X1
arylalkylamine N-acetyltransferase 1 isoform X1
arylalkylamine N-acetyltransferase 1 isoform X2
uncharacterized LOC125502085, transcript variant X3
uncharacterized LOC125502085, transcript variant X2
uncharacterized LOC125502085, transcript variant X1
uncharacterized LOC110117019, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC110117019, transcript variant X2
uncharacterized LOC110117019, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized LOC105686728, transcript variant X1
uncharacterized LOC105686728, transcript variant X2
uncharacterized protein LOC105686728 isoform X1
uncharacterized protein LOC105686728 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
major facilitator superfamily domain-containing protein 6, transcript variant X2
major facilitator superfamily domain-containing protein 6, transcript variant X1
major facilitator superfamily domain-containing protein 6
uncharacterized LOC105686291, transcript variant X1
uncharacterized LOC105686291, transcript variant X3
uncharacterized LOC105686291, transcript variant X2
uncharacterized protein LOC105686291 isoform X1
uncharacterized protein LOC105686291 isoform X3
uncharacterized protein LOC105686291 isoform X2
uncharacterized protein KIAA1143 homolog
uncharacterized LOC105686656, transcript variant X6
uncharacterized LOC105686656, transcript variant X2
uncharacterized LOC105686656, transcript variant X1
uncharacterized LOC105686656, transcript variant X5
uncharacterized LOC105686656, transcript variant X8
uncharacterized LOC105686656, transcript variant X7
uncharacterized LOC105686656, transcript variant X4
uncharacterized LOC105686656, transcript variant X3
uncharacterized protein LOC105686656 isoform X1
uncharacterized protein LOC105686656 isoform X2
serine/threonine-protein phosphatase 6 regulatory subunit 3, transcript variant X5
serine/threonine-protein phosphatase 6 regulatory subunit 3, transcript variant X4
serine/threonine-protein phosphatase 6 regulatory subunit 3, transcript variant X3
serine/threonine-protein phosphatase 6 regulatory subunit 3, transcript variant X2
serine/threonine-protein phosphatase 6 regulatory subunit 3, transcript variant X1
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X3
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X5
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X4
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X2
serine/threonine-protein phosphatase 6 regulatory subunit 3 isoform X1
mitochondrial carrier homolog 2-like, transcript variant X1
mitochondrial carrier homolog 2-like, transcript variant X2
mitochondrial carrier homolog 2-like isoform X1
mitochondrial carrier homolog 2-like isoform X2
transmembrane protein 258, transcript variant X1
transmembrane protein 258, transcript variant X2
uncharacterized LOC105686135, transcript variant X1
uncharacterized LOC105686135, transcript variant X2
uncharacterized protein LOC105686135 isoform X1
uncharacterized protein LOC105686135 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
transcriptional regulator ERG homolog, transcript variant X3
transcriptional regulator ERG homolog, transcript variant X2
transcriptional regulator ERG homolog, transcript variant X1
transcriptional regulator ERG homolog isoform X1
transcriptional regulator ERG homolog isoform X2
uncharacterized LOC105686255, transcript variant X1
uncharacterized LOC105686255, transcript variant X2
uncharacterized LOC105686255, transcript variant X3
DENN domain-containing protein 1A, transcript variant X1
DENN domain-containing protein 1A, transcript variant X2
DENN domain-containing protein 1A, transcript variant X3
DENN domain-containing protein 1B isoform X1
DENN domain-containing protein 1A isoform X3
DENN domain-containing protein 1B isoform X2
valine--tRNA ligase, transcript variant X1
valine--tRNA ligase, transcript variant X2
WW domain-containing adapter protein with coiled-coil homolog, transcript variant X2
WW domain-containing adapter protein with coiled-coil homolog, transcript variant X1
WW domain-containing adapter protein with coiled-coil homolog isoform X2
WW domain-containing adapter protein with coiled-coil homolog isoform X1
carnitine O-palmitoyltransferase 1, liver isoform, transcript variant X4
carnitine O-palmitoyltransferase 1, liver isoform, transcript variant X3
carnitine O-palmitoyltransferase 1, liver isoform, transcript variant X5
carnitine O-palmitoyltransferase 1, liver isoform, transcript variant X2
carnitine O-palmitoyltransferase 1, liver isoform, transcript variant X1
carnitine O-palmitoyltransferase 1, liver isoform isoform X3
carnitine O-palmitoyltransferase 1, liver isoform isoform X2
carnitine O-palmitoyltransferase 1, liver isoform isoform X1
carnitine O-palmitoyltransferase 1, liver isoform isoform X4
uncharacterized LOC105686430, transcript variant X2
uncharacterized LOC105686430, transcript variant X1
putative E3 ubiquitin-protein ligase UBR7
uncharacterized LOC105686426, transcript variant X1
uncharacterized LOC105686426, transcript variant X2
uncharacterized LOC105686426, transcript variant X4
uncharacterized LOC105686426, transcript variant X3
DDB1- and CUL4-associated factor 11, transcript variant X1
DDB1- and CUL4-associated factor 11, transcript variant X2
DDB1- and CUL4-associated factor 11 isoform X2
DDB1- and CUL4-associated factor 11 isoform X1
putative serine protease K12H4.7, transcript variant X3
putative serine protease K12H4.7, transcript variant X1
putative serine protease K12H4.7, transcript variant X4
putative serine protease K12H4.7, transcript variant X2
uncharacterized LOC105686509, transcript variant X4
uncharacterized LOC105686509, transcript variant X6
uncharacterized LOC105686509, transcript variant X5
uncharacterized LOC105686509, transcript variant X1
uncharacterized LOC105686509, transcript variant X2
uncharacterized LOC105686509, transcript variant X8
uncharacterized LOC105686509, transcript variant X3
uncharacterized LOC105686509, transcript variant X7
uncharacterized LOC105686509, transcript variant X9
uncharacterized protein LOC105686509 isoform X1
uncharacterized protein LOC105686509 isoform X2
transcription initiation factor TFIID subunit 4, transcript variant X2
transcription initiation factor TFIID subunit 4, transcript variant X6
transcription initiation factor TFIID subunit 4, transcript variant X1
transcription initiation factor TFIID subunit 4, transcript variant X5
transcription initiation factor TFIID subunit 4, transcript variant X4
transcription initiation factor TFIID subunit 4, transcript variant X3
transcription initiation factor TFIID subunit 4 isoform X2
transcription initiation factor TFIID subunit 4 isoform X4
transcription initiation factor TFIID subunit 4 isoform X1
transcription initiation factor TFIID subunit 4 isoform X3
peptidoglycan-recognition protein LC-like
peptidoglycan-recognition protein SA-like, transcript variant X1
peptidoglycan-recognition protein SA-like, transcript variant X2
peptidoglycan-recognition protein SA-like, transcript variant X3
peptidoglycan-recognition protein SA-like
mitogen-activated protein kinase kinase kinase 13, transcript variant X4
mitogen-activated protein kinase kinase kinase 13, transcript variant X1
mitogen-activated protein kinase kinase kinase 13, transcript variant X2
mitogen-activated protein kinase kinase kinase 12 isoform X1
mitogen-activated protein kinase kinase kinase 12 isoform X2
mitogen-activated protein kinase kinase kinase 13, transcript variant X3
mitogen-activated protein kinase kinase kinase 12 isoform X3
mitogen-activated protein kinase kinase kinase 13 isoform X4
uncharacterized LOC105686524, transcript variant X2
uncharacterized LOC105686524, transcript variant X1
DNA primase large subunit-like, transcript variant X2
DNA primase large subunit-like, transcript variant X1
DNA primase large subunit-like isoform X1
uncharacterized protein LOC105686522 isoform X2
magnesium-dependent phosphatase 1-like, transcript variant X2
magnesium-dependent phosphatase 1-like, transcript variant X1
magnesium-dependent phosphatase 1-like isoform X2
magnesium-dependent phosphatase 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
zinc finger RNA-binding protein, transcript variant X2
zinc finger RNA-binding protein, transcript variant X1
zinc finger RNA-binding protein isoform X2
zinc finger RNA-binding protein isoform X1
zinc finger RNA-binding protein, transcript variant X3
zinc finger RNA-binding protein isoform X3
MAPK regulated corepressor interacting protein 2, transcript variant X2
MAPK regulated corepressor interacting protein 2, transcript variant X1
MAPK regulated corepressor interacting protein 2 isoform X2
MAPK regulated corepressor interacting protein 2 isoform X1
TOM1-like protein 2, transcript variant X4
TOM1-like protein 2, transcript variant X5
TOM1-like protein 2, transcript variant X3
TOM1-like protein 2, transcript variant X2
TOM1-like protein 2, transcript variant X1
dynein regulatory complex subunit 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dynein regulatory complex subunit 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
dynein regulatory complex subunit 3-like isoform X1
dynein regulatory complex subunit 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
dynein regulatory complex subunit 3-like isoform X2
enoyl-CoA delta isomerase 1, mitochondrial-like
dual specificity mitogen-activated protein kinase kinase dSOR1, transcript variant X1
dual specificity mitogen-activated protein kinase kinase dSOR1, transcript variant X2
dual specificity mitogen-activated protein kinase kinase dSOR1 isoform X1
dual specificity mitogen-activated protein kinase kinase dSOR1 isoform X2
sodium/potassium-transporting ATPase subunit alpha-B-like
60S ribosomal protein L17, transcript variant X1
60S ribosomal protein L17, transcript variant X2
eukaryotic translation initiation factor 3 subunit F
secretory carrier-associated membrane protein 5A, transcript variant X2
secretory carrier-associated membrane protein 5A, transcript variant X1
secretory carrier-associated membrane protein 5A
TP53-binding protein 1-like, transcript variant X1
TP53-binding protein 1-like, transcript variant X2
TP53-binding protein 1-like, transcript variant X3
COMM domain-containing protein 10-like, transcript variant X2
COMM domain-containing protein 10-like, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 47, transcript variant X7
ubiquitin carboxyl-terminal hydrolase 47, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 47, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 47, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 47, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 47, transcript variant X10
ubiquitin carboxyl-terminal hydrolase 47, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 47, transcript variant X6
ubiquitin carboxyl-terminal hydrolase 47, transcript variant X9
ubiquitin carboxyl-terminal hydrolase 47, transcript variant X8
ubiquitin carboxyl-terminal hydrolase 47 isoform X1
ubiquitin carboxyl-terminal hydrolase 47 isoform X2
E3 ubiquitin-protein ligase RFWD3-like, transcript variant X2
E3 ubiquitin-protein ligase RFWD3-like, transcript variant X1
E3 ubiquitin-protein ligase RFWD3-like isoform X1
E3 ubiquitin-protein ligase RFWD3-like isoform X2
E3 ubiquitin-protein ligase RFWD3-like, transcript variant X3
E3 ubiquitin-protein ligase RFWD3-like isoform X3
ubiquitin-conjugating enzyme E2-22 kDa, transcript variant X1
ubiquitin-conjugating enzyme E2-22 kDa, transcript variant X2
ubiquitin-conjugating enzyme E2-22 kDa isoform X1
ubiquitin-conjugating enzyme E2-22 kDa isoform X2
ribose-phosphate pyrophosphokinase 1, transcript variant X1
ribose-phosphate pyrophosphokinase 1, transcript variant X4
ribose-phosphate pyrophosphokinase 1, transcript variant X2
ribose-phosphate pyrophosphokinase 1, transcript variant X3
ribose-phosphate pyrophosphokinase 1, transcript variant X5
ribose-phosphate pyrophosphokinase 1 isoform X1
ribose-phosphate pyrophosphokinase 1 isoform X4
ribose-phosphate pyrophosphokinase 1 isoform X2
ribose-phosphate pyrophosphokinase 1 isoform X3
ribose-phosphate pyrophosphokinase 1 isoform X5
metallophosphoesterase domain-containing protein 1
uncharacterized LOC105686631, transcript variant X1
uncharacterized LOC105686631, transcript variant X2
uncharacterized LOC125501990, transcript variant X2
uncharacterized LOC125501990, transcript variant X1
uncharacterized protein LOC125501990 isoform X1
uncharacterized protein LOC125501990 isoform X2
uncharacterized LOC105686287, transcript variant X4
uncharacterized LOC105686287, transcript variant X3
uncharacterized LOC105686287, transcript variant X2
uncharacterized LOC105686287, transcript variant X1
prominin-like protein, transcript variant X1
prominin-like protein, transcript variant X2
prominin-like protein, transcript variant X4
prominin-like protein, transcript variant X3
prominin-like protein, transcript variant X5
splicing factor 3B subunit 1, transcript variant X1
splicing factor 3B subunit 1, transcript variant X2
leucine-rich repeat-containing protein 59
phosphate carrier protein, mitochondrial-like, transcript variant X3
phosphate carrier protein, mitochondrial-like, transcript variant X2
phosphate carrier protein, mitochondrial-like, transcript variant X1
uncharacterized protein LOC105686540 isoform X1
uncharacterized protein LOC105686540 isoform X2
phosphate carrier protein, mitochondrial-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
phosphate carrier protein, mitochondrial-like isoform X3
uncharacterized LOC105686131, transcript variant X1
uncharacterized LOC105686131, transcript variant X2
uncharacterized protein LOC105686131 isoform X1
uncharacterized protein LOC105686131 isoform X2
putative methyltransferase NSUN7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
putative methyltransferase NSUN7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC105686276 isoform X1
putative methyltransferase NSUN7 isoform X2
odorant receptor 82a-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
odorant receptor 82a-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC105686130 isoform X2
uncharacterized LOC110117011, transcript variant X1
uncharacterized LOC110117011, transcript variant X2
28S ribosomal protein S35, mitochondrial
uncharacterized LOC105686128, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
uncharacterized LOC105686128, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized protein LOC105686128 isoform X1
uncharacterized protein LOC105686128 isoform X2
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial, transcript variant X1
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial, transcript variant X3
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial, transcript variant X2
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial isoform X1
pyruvate dehydrogenase [acetyl-transferring]-phosphatase 1, mitochondrial isoform X2
vacuolar protein sorting-associated protein 4
F-box/WD repeat-containing protein 7, transcript variant X6
F-box/WD repeat-containing protein 7, transcript variant X5
F-box/WD repeat-containing protein 7, transcript variant X2
F-box/WD repeat-containing protein 7, transcript variant X3
F-box/WD repeat-containing protein 7, transcript variant X4
F-box/WD repeat-containing protein 7, transcript variant X1
eukaryotic translation initiation factor eIF1
la-related protein Larp4B, transcript variant X2
la-related protein Larp4B, transcript variant X4
la-related protein Larp4B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
la-related protein Larp4B, transcript variant X1
la-related protein Larp4B, transcript variant X5
uncharacterized LOC105686277, transcript variant X2
uncharacterized LOC105686277, transcript variant X3
uncharacterized LOC105686277, transcript variant X4
uncharacterized LOC105686277, transcript variant X1
phospholipid-transporting ATPase ID, transcript variant X7
phospholipid-transporting ATPase ID, transcript variant X2
phospholipid-transporting ATPase ID, transcript variant X1
phospholipid-transporting ATPase ID, transcript variant X6
phospholipid-transporting ATPase ID, transcript variant X5
phospholipid-transporting ATPase ID, transcript variant X4
phospholipid-transporting ATPase ID, transcript variant X3
phospholipid-transporting ATPase ID isoform X6
phospholipid-transporting ATPase ID isoform X5
phospholipid-transporting ATPase ID isoform X4
phospholipid-transporting ATPase ID isoform X3
phospholipid-transporting ATPase ID isoform X2
phospholipid-transporting ATPase ID isoform X1
ATP-binding cassette sub-family B member 10, mitochondrial, transcript variant X1
ATP-binding cassette sub-family B member 10, mitochondrial, transcript variant X2
ATP-binding cassette sub-family B member 10, mitochondrial isoform X1
ATP-binding cassette sub-family B member 10, mitochondrial isoform X2
zinc finger CCCH domain-containing protein 14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
mitochondrial import inner membrane translocase subunit TIM44
geranylgeranyl transferase type-1 subunit beta
39S ribosomal protein L34, mitochondrial
mitochondrial mRNA pseudouridine synthase RPUSD3-like
mitochondrial import inner membrane translocase subunit TIM50-C-like
uncharacterized LOC125502086, transcript variant X3
uncharacterized LOC125502086, transcript variant X2
uncharacterized LOC125502086, transcript variant X1
uncharacterized LOC105686596, transcript variant X4
uncharacterized LOC105686596, transcript variant X1
uncharacterized LOC105686596, transcript variant X3
uncharacterized LOC105686596, transcript variant X5
uncharacterized LOC105686596, transcript variant X2
uncharacterized LOC105686681, transcript variant X4
uncharacterized LOC105686681, transcript variant X5
uncharacterized LOC105686681, transcript variant X1
uncharacterized LOC105686681, transcript variant X3
uncharacterized LOC105686681, transcript variant X2
RYamide receptor-like, transcript variant X2
RYamide receptor-like, transcript variant X3
RYamide receptor-like, transcript variant X1
melatonin receptor type 1B-like isoform X1
queuine tRNA-ribosyltransferase accessory subunit 2, transcript variant X2
queuine tRNA-ribosyltransferase accessory subunit 2, transcript variant X4
queuine tRNA-ribosyltransferase accessory subunit 2, transcript variant X1
queuine tRNA-ribosyltransferase accessory subunit 2, transcript variant X3
queuine tRNA-ribosyltransferase accessory subunit 2 isoform X1
queuine tRNA-ribosyltransferase accessory subunit 2 isoform X2
ZZ-type zinc finger-containing protein 3
transcription initiation factor TFIID subunit 1
serine/threonine-protein kinase PRP4 homolog, transcript variant X3
serine/threonine-protein kinase PRP4 homolog, transcript variant X2
serine/threonine-protein kinase PRP4 homolog, transcript variant X1
serine/threonine-protein kinase PRP4 homolog, transcript variant X4
serine/threonine-protein kinase PRP4 homolog, transcript variant X5
serine/threonine-protein kinase PRP4 homolog isoform X1
serine/threonine-protein kinase PRP4 homolog isoform X2
inositol monophosphatase 1, transcript variant X2
inositol monophosphatase 1, transcript variant X1
b(0,+)-type amino acid transporter 1-like
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X1
calcium-binding mitochondrial carrier protein SCaMC-1-B isoform X1
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X5
calcium-binding mitochondrial carrier protein SCaMC-2-B isoform X5
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X3
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X3
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X4
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X4
calcium-binding mitochondrial carrier protein SCaMC-2-B, transcript variant X2
calcium-binding mitochondrial carrier protein SCaMC-2 isoform X2
anaphase-promoting complex subunit 5, transcript variant X1
anaphase-promoting complex subunit 5, transcript variant X2
anaphase-promoting complex subunit 5 isoform X1
anaphase-promoting complex subunit 5 isoform X2
uncharacterized LOC105686292, transcript variant X4
uncharacterized LOC105686292, transcript variant X1
uncharacterized LOC105686292, transcript variant X3
uncharacterized LOC105686292, transcript variant X2
uncharacterized protein LOC105686292 isoform X2
uncharacterized protein LOC105686292 isoform X1
uncharacterized LOC125499669, transcript variant X1
uncharacterized LOC125499669, transcript variant X2
uncharacterized LOC125499669, transcript variant X3
uncharacterized protein LOC125499669 isoform X1
uncharacterized protein LOC125499669 isoform X2
zinc finger and BTB domain-containing protein 14-like, transcript variant X3
zinc finger and BTB domain-containing protein 14-like, transcript variant X1
zinc finger and BTB domain-containing protein 14-like, transcript variant X5
zinc finger and BTB domain-containing protein 14-like, transcript variant X2
zinc finger and BTB domain-containing protein 14-like, transcript variant X4
zinc finger and BTB domain-containing protein 14-like isoform X2
zinc finger and BTB domain-containing protein 14-like isoform X1
methyltransferase-like protein 17, mitochondrial, transcript variant X2
methyltransferase-like protein 17, mitochondrial, transcript variant X1
methyltransferase-like protein 17, mitochondrial isoform X1
methyltransferase-like protein 17, mitochondrial isoform X2
methyltransferase-like protein 17, mitochondrial, transcript variant X3
methyltransferase-like protein 17, mitochondrial isoform X3
methyltransferase-like protein 17, mitochondrial, transcript variant X4
methyltransferase-like protein 17, mitochondrial isoform X4
probable cytochrome P450 303a1, transcript variant X2
probable cytochrome P450 303a1, transcript variant X1
probable cytochrome P450 303a1 isoform X1
probable cytochrome P450 303a1 isoform X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A-like
palmitoyltransferase ZDHHC3, transcript variant X1
palmitoyltransferase ZDHHC3, transcript variant X3
palmitoyltransferase ZDHHC3, transcript variant X6
palmitoyltransferase ZDHHC3, transcript variant X2
palmitoyltransferase ZDHHC3, transcript variant X4
palmitoyltransferase ZDHHC3, transcript variant X5
nose resistant to fluoxetine protein 6-like
uncharacterized LOC125502045, transcript variant X3
uncharacterized LOC125502045, transcript variant X2
uncharacterized LOC125502045, transcript variant X1
uncharacterized protein LOC125502045 isoform X1
uncharacterized protein LOC125502045 isoform X2
uncharacterized protein LOC125502045 isoform X3
stress response protein NST1, transcript variant X2
stress response protein NST1, transcript variant X1
stress response protein NST1, transcript variant X3
calponin homology domain-containing protein DDB_G0272472 isoform X3
nuclear factor of activated T-cells 5, transcript variant X3
nuclear factor of activated T-cells 5 isoform X3
nuclear factor of activated T-cells 5, transcript variant X2
nuclear factor of activated T-cells 5 isoform X2
nuclear factor of activated T-cells 5, transcript variant X1
nuclear factor of activated T-cells 5, transcript variant X4
nuclear factor of activated T-cells 5 isoform X1
nuclear factor of activated T-cells 5 isoform X4
SH2 domain-containing protein 3C, transcript variant X1
SH2 domain-containing protein 3C, transcript variant X2
SH2 domain-containing protein 3C isoform X1
SH2 domain-containing protein 3C isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 668
lysosomal thioesterase PPT2 homolog, transcript variant X2
lysosomal thioesterase PPT2 homolog, transcript variant X1
lysosomal thioesterase PPT2 homolog isoform X1
lysosomal thioesterase PPT2 homolog isoform X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1
28S ribosomal protein S28, mitochondrial
uncharacterized LOC125502126, transcript variant X1
uncharacterized LOC125502126, transcript variant X2
protein ALP1-like, transcript variant X1
protein ALP1-like, transcript variant X2
uncharacterized LOC110117380, transcript variant X1
uncharacterized LOC110117380, transcript variant X2
uncharacterized LOC110117380, transcript variant X4
uncharacterized LOC110117380, transcript variant X3
uncharacterized LOC110117380, transcript variant X5
protein maelstrom homolog, transcript variant X2
protein maelstrom homolog, transcript variant X1
uncharacterized LOC125502109, transcript variant X1
uncharacterized LOC125502109, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC125502108, transcript variant X2
uncharacterized LOC125502108, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125502107, transcript variant X2
uncharacterized LOC125502107, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
piggyBac transposable element-derived protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 70% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 41% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
uncharacterized LOC125502035, transcript variant X1
uncharacterized LOC125502035, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125502026, transcript variant X2
uncharacterized LOC125502026, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110116957, transcript variant X1
uncharacterized LOC110116957, transcript variant X2
uncharacterized protein LOC110116957 isoform X2
uncharacterized protein LOC110116957 isoform X1
uncharacterized LOC125502033, transcript variant X3
uncharacterized LOC125502033, transcript variant X4
uncharacterized LOC125502033, transcript variant X2
uncharacterized LOC125502033, transcript variant X5
uncharacterized protein LOC125502033 isoform X2
uncharacterized LOC125502033, transcript variant X1
uncharacterized protein LOC125502033 isoform X1
uncharacterized LOC125502025, transcript variant X2
uncharacterized protein LOC125502025 isoform X2
uncharacterized LOC125502025, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 67% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein LOC125502025 isoform X1
uncharacterized LOC125502036, transcript variant X2
uncharacterized LOC125502036, transcript variant X1
uncharacterized LOC125502022, transcript variant X1
uncharacterized LOC125502022, transcript variant X2
uncharacterized protein DDB_G0287625-like
dihydroorotate dehydrogenase (quinone), mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125502028, transcript variant X1
uncharacterized LOC125502028, transcript variant X2
uncharacterized protein LOC125502028 isoform X2
uncharacterized protein LOC125502028 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
protein ALP1-like, transcript variant X3
uncharacterized protein LOC105683007 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 51% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
uncharacterized LOC125502153, transcript variant X1
uncharacterized protein LOC125502153 isoform X1
uncharacterized LOC125502153, transcript variant X2
uncharacterized protein LOC125502153 isoform X2
uncharacterized LOC105691142, transcript variant X2
uncharacterized LOC105691142, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 8% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 56% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125502103, transcript variant X5
uncharacterized LOC125502103, transcript variant X4
uncharacterized LOC125502103, transcript variant X3
uncharacterized LOC125502103, transcript variant X6
uncharacterized LOC125502103, transcript variant X2
uncharacterized LOC125502103, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 44% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125502104, transcript variant X2
uncharacterized LOC125502104, transcript variant X1
uncharacterized LOC125502104, transcript variant X5
uncharacterized LOC125502104, transcript variant X4
uncharacterized LOC125502104, transcript variant X3
uncharacterized LOC125502104, transcript variant X6
uncharacterized LOC125501999, transcript variant X5
uncharacterized LOC125501999, transcript variant X7
uncharacterized LOC125501999, transcript variant X8
uncharacterized LOC125501999, transcript variant X6
uncharacterized LOC125501999, transcript variant X3
uncharacterized LOC125501999, transcript variant X1
uncharacterized LOC125501999, transcript variant X4
uncharacterized LOC125501999, transcript variant X2
uncharacterized LOC105693641, transcript variant X3
uncharacterized LOC105693641, transcript variant X1
uncharacterized LOC105693641, transcript variant X2
uncharacterized protein LOC105693641 isoform X3
uncharacterized protein LOC105693641 isoform X2
uncharacterized protein LOC105693641 isoform X1
uncharacterized LOC105693654, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC105693654, transcript variant X2
uncharacterized LOC125502121, transcript variant X2
uncharacterized LOC125502121, transcript variant X3
uncharacterized LOC125502121, transcript variant X4
uncharacterized LOC125502121, transcript variant X1
ankyrin repeat and MYND domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
uncharacterized LOC125502119, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125502119, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC125502119, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC125502119 isoform X3
uncharacterized protein LOC125502119 isoform X2
uncharacterized protein LOC125502119 isoform X1